FORT LEE, N.J.--(BUSINESS WIRE)--Neurologix, Inc. (OTCBB: NRGX), a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced today that it is scheduled to present at the Rodman & Renshaw 11th Annual Healthcare Conference. John Mordock, Neurologix President and Chief Executive Officer, will discuss the company’s business strategy and corporate overview from 2:25 – 2:55 pm (ET) on September 9. The conference is being held September 9 – 11 in New York City at the New York Palace Hotel.
